12 Feb Peter Fedichev
Dr. Peter recently published an article in bioRxiv about “Identification of a blood test-based biomarker of aging through deep learning of aging trajectories in large phenotypic datasets of mice”.
In the article they proposed and characterized a new biomarker of aging and fragility in rats trained from the large set of the most conventional and easily measurable blood parameters.
Dr. Fedichev is a passionate scientist with training in biophysics, bioinformatics and condensed matter physics. He is the Founder and Chief Science Officer of Gero LLC. Gero is a data-driven longevity startup focused on developing therapies that will strongly prolong a healthy human life.